Impact of Transcutaneous Spinal Stimulation on Blood Pressure and Orthostasis in Spinal Cord Injury

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorKessler Foundation

About this trial

The purpose of this study is to learn whether stimulation applied to the spinal cord through the skin (called transcutaneous spinal stimulation) can help control blood pressure in people with a spinal cord injury.

The main questions this study attempts to solve:

1. What are the immediate effects of spinal cord transcutaneous stimulation on BP? 2. Does stimulation produce lasting improvements in BP regulation and subsequently, daily function?

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals with a SCI ≥ 1 year after injury

Injury level ≥ T6 (thoracic level)

AIS grade A-C

Persistent hypotension (SBP < 90mmHg)

Disqualifiers

Current illness (e.g., infection, a pressure injury that might interfere with the intervention)

Ventilator-dependent

History of implanted brain/spine/nerve stimulators

Cardiac pacemaker/defibrillator or intra-cardiac lines

Trial design

Design model

Single group

Treatments tested in this trial

  • Tilt test with stimulation (real-time effects): Intervention 1

    Device

    While lying supine, participants will be strapped to a Hi-Low tilt-table bed. The bed will gradually be tilted to a 70 degrees tilt, during which time continuous hemodynamic measures will be recorded. This position will be maintained for 30 minutes. During tilt, transcutaneous stimulation will be applied, using the configuration that was chosen based on the mapping sessions.

  • 20 sessions of stimulation (Intervention 2)

    Device

    Participants will undergo 20 separate 30-minute sessions of transcutaneous spinal cord stimulation while seated in their wheelchairs

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: participants with chronic SCIs.Experimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Systolic blood pressure

Evaluate changes in blood pressure during an orthostatic tilt test comparing stimulation to no stimulation.

Time frame
1 month
2

Systolic blood pressure

changes in blood pressure drop with tilt (no stimulation) from baseline testing to tilt test (no stimulation) after 20 sessions of stimulation

Time frame
Through study completion, an average of 5 months

Secondary outcomes

1

duration in tilt test

how long the participant was able to stay in an orthostatic provocation (70 degrees tilt in tilt table)

Time frame
Through study completion, an average of 5 months
2

Orthostatic symptoms questionnaire

A designated questionnaire evaluates symptoms such as headaches, dizziness, blurred vision, nausea, weakness, confusion, fatigue, ringing in the ears, and feeling of passing out. Recorded every 5 minutes (or sooner if symptoms worsen). Participants rate each symptom on a scale of 0 to 10, with 10 indicating the highest severity.

Time frame
Through study completion, an average of 5 months
3

24-hour ABPM OH events - taken at home

Parameters are recorded automatically every 15 min during the day and every 60 min at night. Participants will be asked to take notes regarding BP-related symptoms, activities and their time-points. Conducted before, halfway through, and after the intervention

Time frame
Through study completion, an average of 5 months
4

Autonomic Dysfunction Following Spinal Cord Injury questionnaire scores

24-item self-reported tool designed for clinical practice and research to assess symptoms of BP instability. It evaluates the frequency and severity of symptoms during high and low BP events

Time frame
Through study completion, an average of 5 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kessler Foundation

Lead sponsor

Montclair State University

Collaborator

This trial is not recruiting at the moment. You can still explore other options: